🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Peter Mac has been awarded $2.3M by NBCF Australia for 3 innovative breast cancer research projects by A/Prof Paul Beavis, Dr Kara Britt) and Ajithkumar Vasanthakumar. More on the projects 👉 bit.ly/4jV33q8

Thrilled to welcome the Children's Cancer CoLab team to Peter Mac this week. We’re excited to work together to advance paediatric cancer research in Australia. L-R: Chair Professor Brendan Murphy, Director David Heath, CEO Dr Udani Reets and Peter Mac Chief Executive Professor Jason Payne.

🧡 During #PalliativeCareWeek, we celebrate our incredible Ward 1A team. They provide compassionate, holistic care—supporting patients and families through symptom relief, decision-making, and living well, their way. #WhatsYourPlan #PalliativeCare

Peter Mac’s Michael Hofman spoke on ABC Melbourne about former President Joe Biden’s prostate cancer diagnosis. Biden visited us in 2016 as part of his government's Cancer Moonshot. We send our support and remain inspired by his commitment to tackling cancer. youtu.be/8bL3qgot32s

On #InternationalClinicalTrialsDay, Peter Mac Radiation Oncology got together to celebrate their research achievements across our five campuses, where 35 clinical trials and 76 research projects are underway incorporating medical, #radiationtherapy and physics research.

Peter Mac is offering a first-of-its-kind in Australia postdoctoral fellowship designed to train a clinician as a laboratory scientist, equipping them to lead an independent discovery science lab. Apply: careers.petermac.org/job/MELBOURNE-…

🧬 New research in nature shows advanced genomic testing can help more people with #Cancer of Unknown Primary get targeted treatment & identify where their cancer started. Led by Collaborative Centre for Genomic Cancer Medicine a joint venture of @unimelb & Peter Mac Cancer Centre. 🔗 petermac.org/about-us/news-…

Join Cancer Australia, Peter Mac Cancer Centre and VCCC Alliance at the ACCN Innovations Showcase on Thursday, 3 July at Peter MacCallum Cancer Centre, Melbourne or online. Explore how networked cancer care can ensure the best cancer care for all. No cost. canceraustralia.gov.au/accn

Honoured to welcome Prof Charles Swanton – global leader in cancer research – to Peter Mac Cancer Centre today. His seminar drew a packed crowd and sparked big ideas on #cancer evolution and prevention. The Francis Crick Institute UCLH

Applications are now open for this unique opportunity to undertake a 2-year clinical fellowship based between two world leading centres, The Christie NHS in the UK and Peter Mac Cancer Centre in Australia. Find out more and apply: healthjobsuk.com/job/v7234944

A new Peter Mac-led trial shows cemiplimab could stop high-risk #skincancer (cSCC) from returning — and reduce disfiguring surgery. 📉 Recurrence: 30% ➡️ 9% 📈 2-year survival: 64% ➡️ 87% Presented at #ASCO25 | Published in NEJM 📚 🔗 petermac.org/about-us/news-…

First 161-terbium-PSMA trial in mCRPC - Michael Hofman Peter Mac Cancer Centre presents good 40% PSA 50 decline, mPFS 9mo, and plans for increasing dose/phase 3 comparisons. New radioligands coming for #prostatecancer. #ASCO25 OncoAlert

Expert discussant #RadOnc Professor Shankar Siva Shankar Siva Peter Mac Cancer Centre bringing Professor #Sparkles to dissect lung orals for ACHILES atezo post CCRT, SWOG Cancer Research Network SBRT+atezo, & R-ALPS at #ASCO25.

Our ANZUP #PCRMIB poster featured at #ASCO25. Well done to DrAndrewWeickhardt and the entire team for this important #bladdercancer study Cancer Australia & #BaCT (Centre for Biostatistics and Clinical Trials) Peter Mac Cancer Centre #MSD Ian Davis

An experimental therapy involving radioactive Terbium, and designed to seek out and kill prostate cancer cells wherever they are in the body, has shown very positive initial results in a first-in-human clinical trial at Peter Mac. Read more: petermac.org/about-us/news-…

Ground-breaking, practice-changing research from Prof Danny Rischin & Prof Sandro Porceddu Peter Mac Cancer Centre and brilliant team of 🌏investigators. 👏 Excellent results for patients with high-risk SCC of skin, presented at #ASCO25 ASCO Full results NEJM ➡️ nejm.org/doi/full/10.10…

A record number of Peter Mac researchers presented at #ASCO25 — with global-impact trials, theranostics leadership, ctDNA breakthroughs & more. 🌍 “Our presence is getting bigger and more impactful each year.” – Prof Jayesh Desai. Read more: petermac.org/about-us/news-…

Prof Shankar Siva has received a $1.5M MRFF grant to lead PRIME-Lung — a trial testing if radiotherapy to the primary tumour can boost outcomes in advanced lung cancer (NSCLC). 🔗 Read more: petermac.org/about-us/news-…

A "game-changing treatment for hidden cancer" that's tipped as practice changing featured in The Age with Peter Mac's Prof Danny Rischin explaining how an immunotherapy drug is having a big impact on patients with cutaneous squamous cell carcinoma. More: theage.com.au/national/out-o…

Proud to host the 5th NET Preceptorship at Peter Mac — bringing together experts from across 🇦🇺 to share knowledge on diagnosing & treating rare neuroendocrine tumours. An electric first day today with so much more to come tomorrow! 🔗 bit.ly/NET2025PM